Deutsche Bank set a $50.00 target price on HB Fuller (NYSE:FUL) in a research note issued to investors on Friday morning, TipRanks reports. The firm currently has a hold rating on the specialty chemicals company’s stock.
A number of other equities research analysts have also weighed in on the stock. Citigroup lowered shares of HB Fuller from a neutral rating to a sell rating and decreased their price objective for the company from $48.00 to $41.00 in a report on Friday. ValuEngine upgraded shares of HB Fuller from a sell rating to a hold rating in a report on Friday, June 28th. TheStreet upgraded shares of HB Fuller from a c+ rating to a b- rating in a report on Tuesday, July 23rd. JPMorgan Chase & Co. decreased their price objective on shares of HB Fuller from $51.00 to $46.00 and set a neutral rating for the company in a report on Friday, June 28th. Finally, Zacks Investment Research lowered shares of HB Fuller from a hold rating to a sell rating in a report on Monday, September 23rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of $51.80.
FUL traded up $0.82 on Friday, reaching $46.56. 472,251 shares of the company traded hands, compared to its average volume of 377,537. HB Fuller has a one year low of $39.22 and a one year high of $53.32. The firm has a fifty day simple moving average of $44.48 and a two-hundred day simple moving average of $46.14. The company has a market cap of $2.38 billion, a P/E ratio of 15.52, a price-to-earnings-growth ratio of 1.28 and a beta of 1.61. The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 1.85.
HB Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.04). HB Fuller had a net margin of 4.78% and a return on equity of 13.24%. The company had revenue of $725.38 million for the quarter, compared to the consensus estimate of $749.18 million. During the same quarter in the previous year, the business earned $0.86 EPS. The company’s quarterly revenue was down 5.8% compared to the same quarter last year. On average, equities analysts forecast that HB Fuller will post 3 earnings per share for the current year.
In other HB Fuller news, VP Timothy J. Keenan sold 7,500 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $48.82, for a total transaction of $366,150.00. Following the transaction, the vice president now owns 27,742 shares of the company’s stock, valued at approximately $1,354,364.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.46% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Macquarie Group Ltd. increased its position in HB Fuller by 0.6% during the 2nd quarter. Macquarie Group Ltd. now owns 1,377,842 shares of the specialty chemicals company’s stock valued at $63,932,000 after purchasing an additional 8,555 shares during the period. Atria Investments LLC purchased a new position in HB Fuller during the 2nd quarter valued at about $1,759,000. BlackRock Inc. increased its position in HB Fuller by 0.8% during the 2nd quarter. BlackRock Inc. now owns 7,608,478 shares of the specialty chemicals company’s stock valued at $353,034,000 after purchasing an additional 57,608 shares during the period. Amundi Pioneer Asset Management Inc. increased its position in HB Fuller by 10.9% during the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 276,094 shares of the specialty chemicals company’s stock valued at $12,810,000 after purchasing an additional 27,130 shares during the period. Finally, Stonebridge Capital Advisors LLC purchased a new position in HB Fuller during the 2nd quarter valued at about $60,000. 97.50% of the stock is currently owned by institutional investors and hedge funds.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
See Also: Bear Market
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.